Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-21

Clinical Trial Update: This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance Were Assessed at Baseline and at 26th Weeks. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing vitamin D3 vs placebo in vitamin D-deficient adults with asthma-COPD overlap (A CO) over 26 weeks; outcomes include lung functi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Asthma-COPD Overlap Syndrome | Phase 2 | Status: COMPLETED